Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis
Abstract
Background Multiple sclerosis (MS) commonly affects young adults at the ages 20 to 40 years old, but it can onset at each age. Late-onset multiple sclerosis (LOMS) is defined as symptoms initiating after the age of 50. Misdiagnosis and a remarkable gap in diagnosis of LOMS is a challenge of the elderly population so in this article we described the proportion of LOMS and the clinical features and phenotype of the disease in this age group. Methods After registration of the study protocol, an electronic search was performed in 3 databases and for full coverage of the published studies, we also checked the references of each related article. Two independent researchers screened the records in title/abstract and full-text stages and extracted the data using a data extraction table. The risk of bias was assessed using Joanna Briggs Institute checklist and meta-analysis was conducted by CMA 2. Only the studies with 50 years old cut-off and using McDonald or Poser diagnostic criteria were included in the meta-analysis. Results After removing duplicated studies, out of 733 results of electronic and hand searching, 31 studies met our inclusion criteria for the systematic review, and 11 of them were included in the quantitative synthesis. With different cut-offs and diagnostic methods 1.1% to 21.3% proportion of LOMS, has been reported in the studies. Meta-analysis reached a 5.01% (95% CI: 3.78% to 6.57%), proportion of LOMS in total MS cases. The female cases were more than males (range between 57.7% to 70.2%) and 64.46% (95% CI: 61.94% to 66.91%) proportion of females has been found in this study. 65.00% (95% CI: 44.71% to 81.02%) proportion of spinal cord involvements and 49.80% (95% CI: 39.28% to 60.24%) proportion of relapsing-remitting multiple sclerosis (RRMS) was also observed in LOMS cases. In 4 of included studies, the progressive form was the predominant phenotype. The most prevalent first disease presentation of LOMS was motor dysfunction (ranges between 100% to 35.4%) followed by sensory problems (ranges between 94% to 5%), visual symptoms (ranges between 22.9% to 5%), and brainstem dysfunction (ranges between 25% to 12.3%). The proportion of positive oligoclonal band (OCB), was varied from 46% to 98% in different studies and positive immunoglobulin G (IgG) index also was seen in 45.04% and 66% of the patients. 2.2% - 12.5% of the LOMS cases had a positive family history. Conclusion In about 5% of cases, MS can be diagnosed at ages above 50 years old. There is an increasing concern of a more progressive form of MS in LOMS cases. Unlike the adult-onset MS, the first presentation of LOMS is usually motor dysfunction. Understanding the proportion and clinical features of LOMS will help clinicians with the diagnosis of MS in this age group and prevention of wrong management plans and complications in these patients. Although the proportion of females is still more than males in LOMS cases; but there is a trend to increase in male cases with aging.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A new diagnosis of MS is uncommon in people older than 50 years (∼5% of cases).
“In our study, all patients treated for MS were older than 50 years, an age group in which a new diagnosis of MS is uncommon (∼5% cases).21”
From Multiple Sclerosis Misdiagnosis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (2026) · cites this paper as [21]
Cites
Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Khalil, I. A., Krohn, K. J., Liang, X., Naghavi, M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30443-5 · Cited by 1,108 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mendis, D. D., Vallamchetla, S. K., Marin Collazo, I. V., Sandhu, S. J. S., & Meschia, J. F. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200430
- Authors
- Naseri, A., Nasiri, E., Sahraian, M. A., Daneshvar, S., & Talebi, M.
- Affiliations
- Tabriz University of Medical Sciences (IR)
- Sina Hospital (IR)
- Corresponding author
- Nasiri, Ehsan
- Sahraian, Mohammad Ali
- Daneshvar, Sara
- Talebi, Mahnaz
- Venue
- Multiple Sclerosis and Related Disorders
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 50
- Pages
- 102816
- ISSN
- 2211-0348 (ISSN-L)
- OpenAlex
- W3127860924
- Cited by
- 142
- References
- 1
- Citations by year
- 2026: 31 · 2025: 39 · 2024: 36 · 2023: 19 · 2022: 14 · 2021: 3
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Multiple Sclerosis and Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tabriz University of Medical Sciences (66395, CRD42020221152)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
- Keywords
- late-onset multiple sclerosis, multiple sclerosis, older adults, clinical features, disease phenotypes, relapsing-remitting multiple sclerosis, progressive multiple sclerosis, spinal cord involvement, motor impairment, sensory symptoms, visual disturbances, misdiagnosis, sex differences, prevalence, diagnostic criteria, age of onset, disability progression, relapse rate, disease-modifying therapy
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Age of Onset, Disease Progression, Multiple Sclerosis, Relapsing-Remitting, Oligoclonal Bands, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review